Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 49 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| TUBG1 | ENSG00000131462 | 0.00 | 0.20 | 0 | 1 |
| AOC3 | ENSG00000131471 | 0.00 | 0.00 | 0 | 0 |
| RAMP2 | ENSG00000131477 | 0.00 | 0.00 | 0 | 0 |
| AOC2 | ENSG00000131480 | 0.00 | 0.00 | 0 | 0 |
| G6PC | ENSG00000131482 | 0.00 | 0.00 | 0 | 0 |
| NDFIP1 | ENSG00000131507 | 0.30 | 0.15 | 1 | 1 |
| TNS4 | ENSG00000131746 | 0.00 | 0.00 | 0 | 0 |
| PRKAB2 | ENSG00000131791 | 0.89 | 0.28 | 3 | 2 |
| FSHB | ENSG00000131808 | 0.00 | 0.00 | 0 | 0 |
| MCCC2 | ENSG00000131844 | 0.00 | 1.09 | 0 | 3 |
| VIMP | ENSG00000131871 | 1.82 | 0.00 | 8 | 0 |
| CHSY1 | ENSG00000131873 | 1.90 | 0.00 | 8 | 0 |
| NR0B2 | ENSG00000131910 | 0.00 | 0.00 | 0 | 0 |
| LGALS3 | ENSG00000131981 | 0.00 | 0.00 | 0 | 0 |
| PODNL1 | ENSG00000132000 | 0.00 | 0.00 | 0 | 0 |
| HSD17B7 | ENSG00000132196 | 0.31 | 0.00 | 2 | 0 |
| CNGA4 | ENSG00000132259 | 0.00 | 0.00 | 0 | 0 |
| RAMP1 | ENSG00000132329 | 0.00 | 0.49 | 0 | 2 |
| PTPRE | ENSG00000132334 | 0.00 | 0.13 | 0 | 1 |
| PRKAA1 | ENSG00000132356 | 0.41 | 0.00 | 2 | 0 |
|
Showing page 49 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.